In breast cancer tissue samples, it has been observed that heightened expression of YAP target genes leads to the activation of TGF-β pathway, highlighting YAP’s regulatory role in TGF-β-dependent EMT (Pseftogas et al., 2020). This evidence concerns the gene YAP1 and breast cancer.